A Practical Oxone®-Mediated, High-Throughput, Solution-Phase Synthesis of Benzimidazoles from 1,2-Phenylenediamines and Aldehydes and its Application to Preparative Scale Synthesis

Abstract

Addition of oxone® to a mixture of a 1,2-phenylenediamine and an aldehyde in wet DMF at room temperature results in rapid formation of benzimidazoles under very mild conditions. The reaction is applicable to a wide range of substrates including aliphatic, aromatic and heteroaromatic aldehydes, and is not significantly affected by steric or electronic effects. In most cases, crude products are isolated in good to excellent yields (59-95%) and homogeneities (86-99%) by simple precipitation or extraction from the reaction mixture and do not require additional purification. Limitations to the scope of this methodology were encountered in cases where aldehydes were sensitive to oxone® under the acidic reaction conditions. The features of this methodology make it particularly well suited for the high-throughput, solution-phase synthesis of benzimidazole libraries. The low cost and simplicity of this procedure makes it equally attractive for preparative-scale syntheses where safety and environmental issues are of greater concern.

benzimidazoles - heterocycles - aldehydes - amines - oxone - combinatorial chemistry

References

1a Spasov AA. Yozhitsa IN. Bugaeva LI. Anisimova VA. Pharm. Chem. J.  1999,  33:  232 

1b Preston PN. Chem. Heterocycl. Compd.  1980,  40:  531 

2a Evans BE. Rittle KE. Bock MG. DiPardo RM. Freidinger RM. Whitter WL. Lundell GF. Veber DF. Anderson PS. Chang RSL. Lotti VJ. Cerino DJ. Chen TB. Kling PJ. Kunkel KA. Springer JP. Hirshfield J. J. Med. Chem.  1988,  31:  2235 

2b Mason JS. Morize I. Menard PR. Cheney DL. Hulme C. Labaudiniere RF. J. Med. Chem.  1999,  42:  3251 

See for example:

3a Chi Y.-C. Sun C.-M. Synlett  2000,  591 

3b Huang W. Scarborough RM. Tetrahedron Lett.  1999,  40:  2665 

3c Wu Z. Rea P. Wickham G. Tetrahedron Lett.  2000,  41:  9871 

3d Thomas JB. Fall MJ. Cooper JB. Burgess JP. Carroll FI. Tetrahedron Lett.  1997,  38:  5099 

3e Phillips GB. Wei GP. Tetrahedron Lett.  1996,  37:  4887 

3f Sun Q. Yan B. Bioorg. Med. Chem. Lett.  1998,  8:  361 

3g Smith JM. Krchák V. Tetrahedron Lett.  1999,  40:  7633 

3h Mayer JP. Lewis GS. McGee C. Bankaitis-Davis D. Tetrahedron Lett.  1998,  39:  6655 

4 Brain CT. Brunton SA. Tetrahedron Lett.  2002,  43:  1893 

5a White AW. Almassy R. Calvert AH. Curtin NJ. Griffin RJ. Hostomsky Z. Maegley K. Newell DR. Srinivasan S. Golding BT. J. Med. Chem.  2000,  43:  4084 

5b Hendrickson JB. Hussoin MS. J. Org. Chem.  1987,  52:  4137 

5c Dunwell DW. Evans D. Smith CE. Williamson WRN. J. Med. Chem.  1975,  18:  692 

5d Güngör T. Fouquet A. Teulon J.-M. Provost D. Cazes M. Cloarec A. J. Med. Chem.  1992,  35:  4455 

5e Barni E. Savarino P. J. Heterocycl. Chem.  1979,  16:  1583 

6a Smith JG. Ho I. Tetrahedron Lett.  1971,  38:  3541 

6b Jonas R. Klockow M. Lues I. Prücher H. Schliep HJ. Wurziger H. Eur. J. Med. Chem.  1993,  28:  129 

7a Blettner CG. König WA. Rühter G. Stenzel W. Schotten T. Synlett  1999,  307 

7b Sun Q. Gatto B. Yu C. Liu A. Liu LF. LaVoie EJ. J. Med. Chem.  1995,  38:  3638 

7c Ben-Alloum A. Bakkas S. Soufiaoui M. Tetrahedron Lett.  1998,  39:  4481 

7d Satz AL. Bruice TC. Bioorg. Med. Chem. Lett.  1999,  9:  3261 

7e Rangarajan M. Kim JS. Sim S.-P. Liu A. Liu LR. LaVoie EJ. Bioorg. Med. Chem.  2000,  8:  2591 

7f Black DSt.C. Kumar N. Wong LCH. Synthesis  1986,  474 

8a Denny WA. Rewcastle GW. Baguley BC. J. Med. Chem.  1990,  33:  814 

8b Dang Q. Brown BS. Erion MD. Tetrahedron Lett.  2000,  41:  6559 

8c Singh MP. Sasmal S. Lu W. Chatterjee MN. Synthesis  2000,  1380 

8d Gravatt GL. Baguley BC. Wilson WR. Denny WA. J. Med. Chem.  1994,  37:  4338 

9a Vanden Eynde JJ. Delfosse F. Lor P. Van Haverbeke Y. Tetrahedron  1995,  51:  5813 

9b Hopkins KT. Wilson WD. Bender BC. McCurdy DR. Hall JE. Tidwell RR. Kumar A. Bajic M. Boykin DW. J. Med. Chem.  1998,  41:  3872 

9c Lombardy RL. Tanious FA. Ramachandran K. Tidwell RR. Wilson WD. J. Med. Chem.  1996,  39:  1452 

10 Chikashita H. Nishida S. Miyazaki M. Morita Y. Itoh K. Bull Chem. Soc. Jpn.  1987,  60:  737 

11 Pätzold F. Zeuner F. Heyer Th. Niclas H.-J. Synth. Commun.  1992,  22:  281 

12a Ridley HF. Spickett RGW. Timmis GM. J. Heterocycl. Chem.  1965,  2:  453 

12b Göker H. Kus C. Boykin DW. Yildiz S. Altanlar N. Bioorg. Med. Chem.  2002,  10:  2589 

13 Yukawa H. Nagatani T. Torisawa Y. Okaichi Y. Tada N. Furuta T. Minamikawa J.-I. Nishi T. Bioorg. Med. Chem. Lett.  1997,  7:  1267 

14a Narsaiah AV. Synlett  2002,  1178 

14b For other uses of oxone® in organic synthesis, see for example: Lee K.-J. You H.-W. Synlett  2001,  105 ; and references cited therein

14c After submission of this manuscript, Borhan et al. reported on the use of oxone^® for the oxidation of aldehydes to carboxylic acids: Travis BR. Sivakumar M. Hollist GO. Borhan B. Org. Lett.  2003,  5:  1031 ; it appears that formation of benzimidazoles under the present reaction conditions is faster than oxidation of the aldehyde substrate to the corresponding carboxylic acid. It is possible however that this latter pathway can become competitive for less reactive substrates and account for some of the lower yields

15 For an alternative reduction of nitro groups with stannous chloride, see for example: Bellamy FD. Ou K. Tetrahedron Lett.  1984,  25:  839 

The formation of an intermediate formate ester from the starting aldehyde through a Baeyer-Villiger oxidation is inferred from detection of the corresponding alcohol. Precedent for this kind of process can be found in the literature, but usually involves organic peracids as oxidant. See for example:

16a Yeager GW. Schissel DN. Synthesis  1991,  63 

16b Krow GR. Org. React.  1993,  43:  251 

16c Occurrence of an oxone^®-promoted Baeyer-Villiger process has been proposed in the literature: Wu X.-Y. She X. Shi Y. J. Am. Chem. Soc.  2002,  124:  8792 ; see also earlier reference (Ref. 14c)

17 DMF alone or its dimethyl acetal can also promote conversion of 1,2-phenylenediamines to 2H-benz-imidazoles, but this usually requires elevated temperatures and is not suspected to occur under the present oxone^®-promoted reaction conditions: Mataka S. Shimojyo Y. Hashimoto I. Tashiro M. Liebigs Ann.  1995,  10:  1823 

18

The ratio of 14 to 15 did not vary significantly upon prolonged reaction times indicating that under the reaction conditions, equilibration of the diamine 15 to benzamidine 3 and eventually to product 14 did not occur.

It is very likely that the quenched reaction mixtures still retain some oxidizing potential and should be disposed of appropriately to avoid hazardous decompositions. It has been reported for example that oxone^® will lose active oxygen slowly under alkaline conditions, see:

19a Kennedy RJ. Stock AM. J. Org. Chem.  1960,  25:  1901 

19b Ball DL. Edwards JO. J. Am. Chem. Soc.  1956,  78:  1125 

20a Chang J. Zhao K. Pan S. Tetrahedron Lett.  2002,  43:  951 ; and references cited therein

20b Hari A. Karan C. Rodrigues WC. Miller BL. J. Org. Chem.  2001,  66:  991